Product Prescribing Issue
11 drugs647 FAERS reportsMedDRA PT
GET
/api/v1/reaction/product-prescribing-issueReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Product Prescribing Issue (11)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Rezafungin1215%
- 2Olutasidenib218.1%
- 3Pralsetinib1368.0%
- 4Depemokimab15.6%
- 5Praziquantel103.4%
- 6Fostamatinib2183.3%
- 7Lotilaner793.2%
- 8Levacetylleucine52.6%
- 9Molnupiravir1142.2%
- 10Butenafine122.1%
- 11Finerenone391.5%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Accidental Exposure To Product2 shared · 0.05
- Wrong Technique In Product Usage Process3 shared · 0.04
- Product Use Issue6 shared · 0.04
- Dysphagia2 shared · 0.04
- Drug Ineffective For Unapproved Indication2 shared · 0.03
- No Adverse Event3 shared · 0.02
- Seizure2 shared · 0.02
- Blood Pressure Increased3 shared · 0.02
- Covid-193 shared · 0.02
- Erythema3 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.